Recor Medical

ReCor Medical is a medical technology company based in Palo Alto, California, focused on innovative therapies for hypertension, a major cardiovascular risk factor. Founded in 2009, it operates as a subsidiary of Otsuka Medical Devices Co., Ltd. The company has developed the Paradise® Ultrasound Renal Denervation (uRDN) System, which utilizes a catheter-based approach to deliver ultrasound energy for effective treatment of resistant hypertension. The Paradise System has shown significant clinical outcomes, including substantial reductions in office systolic blood pressure over various timeframes. ReCor Medical emphasizes safety and efficacy in its procedures and supports healthcare professionals with guidance on using its technology. The company has achieved CE mark approval in the European Union and FDA approval in the United States, allowing it to reach healthcare providers treating patients with hypertension.